Sanofi eyes approval of COVID-19 vaccine by first half of 2021

  • PARIS French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain’s GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
  • Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.
  • We are being guided by our dialog with regulatory authorities, Sanofi research chief John Reed told reporters, when asked about the accelerated time frame.

Read full article: business.financialpost.com